Clinical Trial Update: Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants [Phase 3]

View source ↗

Summary

Phase 3 trial assessing immunogenicity and safety of Menitorix vaccine in preterm infants completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease Prevention
• Neisseria Meningitidis Disease Prevention

Drugs mentioned

• Menitorix

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Status: COMPLETED | Results posted: 2010-01-22